Home > Financial Ratios > TTK HEALTHCARE

TTK HEALTHCARE
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for TTK HEALTHCARE
Please provide your vote to see the results

TTK HEALTHCARE Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 6.1525.42108.7630.47-21.08

What is the latest Core EBITDA Growth ratio of TTK HEALTHCARE ?

The latest Core EBITDA Growth ratio of TTK HEALTHCARE is 6.15 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar20256.15
Mar202425.42
Mar2023108.76
Mar202230.47
Mar2021-21.08

How is Core EBITDA Growth of TTK HEALTHCARE Trending?

Years Core EBITDA Growth % Change
Mar2025 6.15
-75.81
Mar2024 25.42
-76.63
Mar2023 108.76
256.94
Mar2022 30.47
Positive
Mar2021 -21.08 -

Other Financial Ratios of TTK HEALTHCARE


Compare Core EBITDA Growth ratio of peers of TTK HEALTHCARE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TTK HEALTHCARE ₹1,596.8 Cr -3.5% -1.9% -30% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹404,468.0 Cr -1.1% 1.9% -8.5% Stock Analytics
DIVIS LABORATORIES ₹182,810.0 Cr 3.5% 18.2% 15.4% Stock Analytics
CIPLA ₹121,170.0 Cr -2.6% -0.9% -3.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹120,300.0 Cr -1.3% 0.8% 11.7% Stock Analytics
DR REDDYS LABORATORIES ₹100,575.0 Cr 0.2% -3.5% -5.8% Stock Analytics


TTK HEALTHCARE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TTK HEALTHCARE

-3.5%

-1.9%

-30%

SENSEX

-2%

2.6%

4.2%


You may also like the below Video Courses